Earnings History Data for Novavax, Inc. (NVAX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Novavax, Inc.

NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as vehicles for the delivery of a wide variety of drugs and other therapeutic products, including certain hormones, anti-bacterial and anti-viral products and vaccine adjuvants.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-11-2024 PM NVAX Novavax, Inc. 1,430 -0.76 -0.87 -1.26 Novavax beats top-line and bottom-line estimates; updates FY24 outlook
[11/12/2024 8:04 AM]
8.44 -0.57 
(-6.38%)
7.96 -1.05 
(-11.65%)
3.53 - 23.86 7,959,888 5,230,000 1,899,116
08-08-2024 PM NVAX Novavax, Inc. 1,620 0.99 1.35 0.58 Novavax GAAP EPS of $0.99 misses by $0.68, revenue of $415.48M misses by $13M
[8/8/2024 7:49 AM]
11.66 0.95 
(8.92%)
8.98 -1.73 
(-16.15%)
3.53 - 23.86 10,356,992 8,380,000 1,371,663
10-05-2024 PM NVAX Novavax, Inc. 625.59 -1.05 -1.04 -3.41 Novavax reports mixed Q1 results; narrows FY24 revenue outlook below estimates
[5/10/2024 3:38 AM]
8.89 4.42 
(98.99%)
10.07 5.60 
(125.28%)
3.53 - 11.00 127,661,248 4,280,000 37,907,560
28-02-2024 PM NVAX Novavax 628.00 -1.44 -0.49 0.00 Novavax GAAP EPS of -$1.44 misses by $0.99, revenue of $291M misses by $30.97M
[2/28/2024 8:01 AM]
4.40 -1.62 
(-26.91%)
4.66 -1.36 
(-22.59%)
3.53 - 11.36 26,578,159 12,600,000 3,141,754
09-11-2023 PM NVAX Novavax, Inc. 669.33 -1.26 -1.82 -2.15 Novavax beats Q3 top and bottom line estimates; initiates Q1 and updates FY23 outlook
[11/9/2023 8:04 AM]
6.72 -0.08 
(-1.18%)
6.97 0.17 
(2.50%)
5.61 - 25.66 8,825,417 5,290,000 398,241
08-08-2023 PM NVAX Novavax, Inc. 695.62 0.58 -1.24 -6.53 Novavax GAAP EPS of $0.58 beats by $1.74, revenue of $424.43M beats by $165.44M
[8/8/2023 6:40 AM]
7.25 -0.27 
(-3.59%)
8.17 0.65 
(8.64%)
5.61 - 62.75 25,212,010 5,220,000 3,675,613
09-05-2023 PM Before the open
(May 9)
NVAX Novavax, Inc. 664.40 -3.41 -3.38 2.56 Novavax reports mixed Q1 earnings; updates FY23 outlook
[5/9/2023 6:36 AM]
9.54 2.09 
(28.12%)
9.03 1.58 
(21.19%)
5.61 - 76.77 39,799,436 3,820,000 1,610,857
28-02-2023 AH 4:00 PM ET
(Feb 28)
NVAX Novavax, Inc. 773.54 -2.28 -0.92 -11.18 Novavax GAAP EPS of -$2.28 misses by $1.27, revenue of $357.4M misses by $25.74M
[2/28/2023 4:06 PM]
6.83 -2.43 
(-26.30%)
6.97 -2.29 
(-24.73%)
6.64 - 91.00 18,728,644 5,230,000 3,066,898
08-11-2022 AH 4:00 PM ET
(Nov 8)
NVAX Novavax, Inc. 1,580 -2.15 2.21 -4.31 Novavax GAAP EPS of -$2.15 misses by $3.79, revenue beats estimates, lowers revenue guidance
[11/8/2022 4:03 PM]
18.62 -1.03 
(-5.24%)
19.65 0.0 
(0.00%)
16.00 - 236.50 5,771,033 4,210,000 66,437
08-08-2022 AH 4:00 PM ET
(Aug 8)
NVAX Novavax, Inc. 4,290 -6.53 5.51 -4.75 Novavax GAAP EPS of -$6.53, revenue of $185.93M misses by $834.07M, lowers 2022 revenue forecast
[8/8/2022 4:03 PM]
40.25 -17.00 
(-29.69%)
40.00 -17.25 
(-30.13%)
34.88 - 277.80 24,836,748 4,600,000 1,781,572
09-05-2022 AH 4:00 PM ET
(May 9)
NVAX Novavax, Inc. 4,580 2.56 3.33 -3.05 Novavax GAAP EPS of $2.56 misses by $0.09, revenue of $703.97M misses by $141.23M
[5/9/2022 4:04 PM]
54.15 0.89 
(1.67%)
42.19 -11.07 
(-20.78%)
42.13 - 277.80 12,071,310 4,309,461 659,547
28-02-2022 AH 4:00 PM ET
(Feb 28)
NVAX Novavax, Inc. 6,040 -11.18 -1.43 -2.70 Novavax Non-GAAP EPS of -$11.18 misses by $9.38, revenue of $222.2M misses by $109.59M
[2/28/2022 4:05 PM]
83.71 0.34 
(0.41%)
79.05 -4.32 
(-5.18%)
66.38 - 277.80 6,429,157 3,770,000 97,111
04-11-2021 AH 4:05 PM ET
(Nov 4)
NVAX Novavax, Inc. 12,840 -4.31 -4.04 -3.21 Novavax EPS misses by $0.58, misses on revenue
[11/4/2021 4:08 PM]
159.02 -20.39 
(-11.36%)
160.50 -18.91 
(-10.54%)
76.59 - 331.68 11,115,817 5,640,000 1,071,681
05-08-2021 AH 4:00 PM ET
(Aug 5)
NVAX Novavax, Inc. 13,970 -4.75 -3.76 -0.30 Novavax EPS misses by $1.50, misses on revenue; shares plummet
[8/5/2021 4:07 PM]
189.36 -46.84 
(-19.83%)
200.00 -36.20 
(-15.33%)
76.59 - 331.68 14,124,369 4,850,000 763,143
10-05-2021 AH 4:00 PM ET
(May 10)
NVAX Novavax, Inc. 12,780 -3.05 -2.65 -0.58 Novavax EPS beats by $0.55, beats on revenue
[5/10/2021 4:03 PM]
138.11 -22.39 
(-13.95%)
135.10 -25.40 
(-15.83%)
19.62 - 331.68 7,602,887 5,230,000 419,397
01-03-2021 AH 4:05 PM ET
(Mar 1)
NVAX Novavax, Inc. 14,900 -2.70 -1.53 -1.13 Novavax EPS misses by $0.46, beats on revenue
[3/1/2021 4:06 PM]
206.81 -33.48 
(-13.93%)
226.95 -13.34 
(-5.55%)
6.77 - 331.68 6,122,307 2,809,915 39,544
09-11-2020 AH 4:00 PM ET
(Nov 9)
NVAX Novavax, Inc. 5,710 -3.21 2.36 -1.03 Novavax EPS misses by $4.94, misses on revenue
[11/9/2020 4:10 PM]
78.58 -11.73 
(-12.99%)
85.32 -4.99 
(-5.53%)
3.54 - 189.40 6,585,151 2,880,346 104,856
10-08-2020 AH 4:05 PM ET
(Aug 10)
NVAX Novavax, Inc. 9,830 -0.30 -0.60 -1.69 Novavax EPS beats by $0.23, beats on revenue
[8/10/2020 4:04 PM]
164.88 -13.63 
(-7.64%)
169.99 -8.52 
(-4.77%)
3.54 - 189.40 9,262,062 7,937,483 219,943